The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Current Classification and Management of Inflammatory Myopathies
Open accessAbstract
Inflammatory disorders of the skeletal muscle include polymyositis (PM), dermatomyositis (DM), (immune mediated) necrotizing myopathy (NM), overlap syndrome with myositis (overlap myositis, OM) including anti-synthetase syndrome (ASS), and inclusion body myositis (IBM). Whereas DM occurs in children and adults, all other forms of myositis mostly develop in middle aged individuals. Apart from a slowly progressive, chronic disease course in IBM, patients with myositis typically present with a subacute onset of weakness of arms and legs, often associated with pain and clearly elevated creatine kinase in the serum. PM, DM and most patients with NM and OM usually respond to immunosuppressive therapy, whereas IBM is largely refractory to treatment. The diagnosis of myositis requires careful and combinatorial assessment of (1) clinical symptoms including pattern of weakness and paraclinical tests such as MRI of the muscle and electromyography (EMG), (2) broad analysis of auto-antibodies associated with myositis, and (3) detailed histopathological work-up of a skeletal muscle biopsy. This review provides a comprehensive overview of the current classification, diagnostic pathway, treatment regimen and pathomechanistic understanding of myositis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Polymyositis and Dermatomyositis: (First of Two Parts)
Bohan, A., & Peter, J. B. (1975) · New England Journal of Medicine · doi:10.1056/nejm197502132920706 · Cited by 5,059
Lundberg, I. E., Tjärnlund, A., Bottai, M., Werth, V. P., Pilkington, C., Visser, M. D., Alfredsson, L., Amato, A. A., Barohn, R. J., Liang, M. H., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-211468 · Cited by 1,557
Polymyositis and dermatomyositis
Dalakas, M. C., & Hohlfeld, R. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14368-1 · Cited by 1,416
Dalakas, M. C., Illa, I., Dambrosia, J. M., Soueidan, S. A., Stein, D. P., Otero, C., Dinsmore, S. T., & McCrosky, S. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292704 · Cited by 1,136
Polymyositis and Dermatomyositis
Hohlfeld, R., Hofmann, W. W., & Hanley, D. F. (1994) · Neurocritical Care · doi:10.1007/978-3-642-87602-8_72 · Cited by 1,083
Myositis‐specific autoantibodies: an important tool to support diagnosis of myositis
Betteridge, Z., & McHugh, N. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12451 · Cited by 1,056
Hoogendijk, J. E., Amato, A. A., Lecky, B. R., Choy, E. H., Lundberg, I. E., Rose, M. R., Vencovsky, J., de Visser, M., & Hughes, R. A. (2004) · Neuromuscular Disorders · doi:10.1016/j.nmd.2004.02.006 · Cited by 950
Inclusion body myositis and myopathies
Griggs, R. C., Askanas, V., DiMauro, S., Engel, A., Karpati, G., Mendell, J. R., & Rowland, L. P. (1995) · Annals of Neurology · doi:10.1002/ana.410380504 · Cited by 837
Dalakas, M. C. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1402225 · Cited by 790
Sato, S., Hirakata, M., Kuwana, M., Suwa, A., Inada, S., Mimori, T., Nishikawa, T., Oddis, C. V., & Ikeda, Y. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21023 · Cited by 747
Lundberg, I. E., Tjärnlund, A., Bottai, M., Werth, V. P., Pilkington, C., de Visser, M., Alfredsson, L., Amato, A. A., Barohn, R. J., Liang, M. H., et al. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40320 · Cited by 730
Oddis, C. V., Reed, A. M., Aggarwal, R., Rider, L. G., Ascherman, D. P., Levesque, M. C., Barohn, R. J., Feldman, B. M., Harris‐Love, M. O., Koontz, D. C., et al. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37754 · Cited by 701
Mammen, A. L., Chung, T., Christopher-Stine, L., Rosen, P., Rosen, A., Doering, K. R., & Casciola-Rosen, L. A. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30156 · Cited by 699
Christopher‐Stine, L., Casciola‐Rosen, L. A., Hong, G., Chung, T., Corse, A. M., & Mammen, A. L. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27572 · Cited by 512
Troyanov, Y., Targoff, I. N., Tremblay, J.-L., Goulet, J.-R., Raymond, Y., & Senécal, J.-L. (2005) · Medicine · doi:10.1097/01.md.0000173991.74008.b0 · Cited by 506
Rider, L. G., Werth, V. P., Huber, A. M., Alexanderson, H., Rao, A. P., Ruperto, N., Herbelin, L., Barohn, R., Isenberg, D., & Miller, F. W. (2011) · Arthritis Care & Research · doi:10.1002/acr.20532 · Cited by 430
Satoh, M., Tanaka, S., Ceribelli, A., Calise, S. J., & Chan, E. K. L. (2017) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8510-y · Cited by 420
Rose, M. R. (2013) · Neuromuscular Disorders · doi:10.1016/j.nmd.2013.08.007 · Cited by 388
Treatment of inclusion-body myositis with IVIg: A double-blind, placebo-controlled study
Dalakas, M. C., Sonies, B., Dambrosia, J., Sekul, E., Cupler, E., & Sivakumar, K. (1997) · Neurology · doi:10.1212/wnl.48.3.712 · Cited by 350
Polymyositis: An overdiagnosed entity
van der Meulen, M. F. G., Bronner, I. M., Hoogendijk, J. E., Burger, H., van Venrooij, W. J., Voskuyl, A. E., Dinant, H. J., Linssen, W. H. J. P., Wokke, J. H. J., & de Visser, M. (2003) · Neurology · doi:10.1212/wnl.61.3.316 · Cited by 332
Miller, F. W. (2001) · Rheumatology · doi:10.1093/rheumatology/40.11.1262 · Cited by 332
Hervier, B., Devilliers, H., Stanciu, R., Meyer, A., Uzunhan, Y., Masseau, A., Dubucquoi, S., Hatron, P.-Y., Musset, L., Wallaert, B., et al. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.06.006 · Cited by 308
Aggarwal, R., Cassidy, E., Fertig, N., Koontz, D. C., Lucas, M., Ascherman, D. P., & Oddis, C. V. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201800 · Cited by 301
The Myositis Autoantibody Phenotypes of the Juvenile Idiopathic Inflammatory Myopathies
Rider, L. G., Shah, M., Mamyrova, G., Huber, A. M., Rice, M. M., Targoff, I. N., & Miller, F. W. (2013) · Medicine · doi:10.1097/md.0b013e31829d08f9 · Cited by 288
Lega, J.-C., Fabien, N., Reynaud, Q., Durieu, I., Durupt, S., Dutertre, M., Cordier, J.-F., & Cottin, V. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.03.004 · Cited by 286
Cytosolic 5′‐nucleotidase 1A autoimmunity in sporadic inclusion body myositis
Benjamin Larman, H., Salajegheh, M., Nazareno, R., Lam, T., Sauld, J., Steen, H., Won Kong, S., Pinkus, J. L., Amato, A. A., Elledge, S. J., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23840 · Cited by 284
The EuroMyositis registry: an international collaborative tool to facilitate myositis research
Lilleker, J. B., Vencovsky, J., Wang, G., Wedderburn, L. R., Diederichsen, L. P., Schmidt, J., Oakley, P., Benveniste, O., Danieli, M. G., Danko, K., et al. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-211868 · Cited by 281
Self-citationAllenbach, Y., Drouot, L., Rigolet, A., Charuel, J. L., Jouen, F., Romero, N. B., Maisonobe, T., Dubourg, O., Behin, A., Laforet, P., et al. (2014) · Medicine · doi:10.1097/md.0000000000000028 · Cited by 278
Classification criteria for polymyositis and dermatomyositis.
Tanimoto, K., Nakano, K., Kano, S., Mori, S., Ueki, H., Nishitani, H., Sato, T., Kiuchi, T., & Ohashi, Y. (1995) · PubMed · Cited by 271
Wallace, K. L., Middleton, S., & Cook, I. J. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70137-5 · Cited by 269
Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM
Chahin, N., & Engel, A. G. (2008) · Neurology · doi:10.1212/01.wnl.0000277527.69388.fe · Cited by 258
Autoantibodies to cytosolic 5′‐nucleotidase 1A in inclusion body myositis
Pluk, H., van Hoeve, B. J. A., van Dooren, S. H. J., Stammen‐Vogelzangs, J., van der Heijden, A., Schelhaas, H. J., Verbeek, M. M., Badrising, U. A., Arnardottir, S., Gheorghe, K., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23822 · Cited by 256
Werner, J. L., Christopher‐Stine, L., Ghazarian, S. R., Pak, K. S., Kus, J. E., Daya, N. R., Lloyd, T. E., & Mammen, A. L. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34673 · Cited by 255
Goebels, N., Michaelis, D., Engelhardt, M., Huber, S., Bender, A., Pongratz, D., Johnson, M. A., Wekerle, H., Tschopp, J., Jenne, D., et al. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118749 · Cited by 251
Evaluation and construction of diagnostic criteria for inclusion body myositis
Lloyd, T. E., Mammen, A. L., Amato, A. A., Weiss, M. D., Needham, M., & Greenberg, S. A. (2014) · Neurology · doi:10.1212/wnl.0000000000000642 · Cited by 247
Walter, M. C., Lochmüller, H., Toepfer, M., Schlotter, B., Reilich, P., Schröder, M., Müller-Felber, W., & Pongratz, D. (2000) · Journal of Neurology · doi:10.1007/s004150050005 · Cited by 235
Autoantibodies to a 140‐kd protein in juvenile dermatomyositis are associated with calcinosis
Gunawardena, H., Wedderburn, L. R., Chinoy, H., Betteridge, Z. E., North, J., Ollier, W. E. R., Cooper, R. G., Oddis, C. V., Ramanan, A. V., Davidson, J. E., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24547 · Cited by 234
A controlled study of intravenous immunoglobulin combined with prednisone in the treatment of IBM
Dalakas, M. C., Koffman, B., Fujii, M., Spector, S., Sivakumar, K., & Cupler, E. (2001) · Neurology · doi:10.1212/wnl.56.3.323 · Cited by 233
Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis
Gordon, P. A., Winer, J. B., Hoogendijk, J. E., & Choy, E. H. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003643.pub4 · Cited by 230
Sporadic inclusion body myositis—diagnosis, pathogenesis and therapeutic strategies
Dalakas, M. C. (2006) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0261 · Cited by 229
Short-Term and Long-Term Outcome of Anti-Jo1-Positive Patients with Anti-Ro52 Antibody
Marie, I., Hatron, P. Y., Dominique, S., Cherin, P., Mouthon, L., Menard, J.-F., Levesque, H., & Jouen, F. (2012) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2011.09.008 · Cited by 228
Inflammatory myopathy with anti-signal recognition particle antibodies: case series of 100 patients
Suzuki, S., Nishikawa, A., Kuwana, M., Nishimura, H., Watanabe, Y., Nakahara, J., Hayashi, Y. K., Suzuki, N., & Nishino, I. (2015) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-015-0277-y · Cited by 227
Long-term outcome in polymyositis and dermatomyositis
Bronner, I. M., van der Meulen, M. F. G., de Visser, M., Kalmijn, S., van Venrooij, W. J., Voskuyl, A. E., Dinant, H. J., Linssen, W. H. J. P., Wokke, J. H. J., & Hoogendijk, J. E. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.045690 · Cited by 215
Epidemiology of inclusion body myositis in the Netherlands: A nationwide study
Badrising, U. A., Maat-Schieman, M., van Duinen, S. G., Breedveld, F., van Doorn, P., van Engelen, B., van den Hoogen, F., Hoogendijk, J., Höweler, C., de Jager, A., et al. (2000) · Neurology · doi:10.1212/wnl.55.9.1385 · Cited by 214
Treatment of sporadic inclusion body myositis with bimagrumab
Amato, A. A., Sivakumar, K., Goyal, N., David, W. S., Salajegheh, M., Praestgaard, J., Lach-Trifilieff, E., Trendelenburg, A.-U., Laurent, D., Glass, D. J., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000001070 · Cited by 210
The clinical features, diagnosis and classification of dermatomyositis
Iaccarino, L., Ghirardello, A., Bettio, S., Zen, M., Gatto, M., Punzi, L., & Doria, A. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.11.005 · Cited by 201
A 12-year follow-up in sporadic inclusion body myositis: an end stage with major disabilities
Cox, F. M., Titulaer, M. J., Sont, J. K., Wintzen, A. R., Verschuuren, J. J. G. M., & Badrising, U. A. (2011) · Brain · doi:10.1093/brain/awr217 · Cited by 201
Schmidt, J., Barthel, K., Wrede, A., Salajegheh, M., Bähr, M., & Dalakas, M. C. (2008) · Brain · doi:10.1093/brain/awn053 · Cited by 198
Self-citationImmunosuppressive drugs and fertility
Leroy, C., Rigot, J.-M., Leroy, M., Decanter, C., Le Mapihan, K., Parent, A.-S., Le Guillou, A.-C., Yakoub-Agha, I., Dharancy, S., Noel, C., et al. (2015) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-015-0332-8 · Cited by 198
Plasma cells in muscle in inclusion body myositis and polymyositis
Greenberg, S. A., Bradshaw, E. M., Pinkus, J. L., Pinkus, G. S., Burleson, T., Due, B., Bregoli, L. S., O’Connor, K. C., & Amato, A. A. (2005) · Neurology · doi:10.1212/01.wnl.0000187124.92826.20 · Cited by 193
Betteridge, Z. E., Gunawardena, H., Chinoy, H., North, J., Ollier, W. E. R., Cooper, R. G., & McHugh, N. J. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.097162 · Cited by 193
Idiopathic inflammatory myopathies and the lung
Lega, J.-C., Reynaud, Q., Belot, A., Fabien, N., Durieu, I., & Cottin, V. (2015) · European Respiratory Review · doi:10.1183/16000617.00002015 · Cited by 190
Aggarwal, R., Rider, L. G., Ruperto, N., Bayat, N., Erman, B., Feldman, B. M., Oddis, C. V., Amato, A. A., Chinoy, H., Cooper, R. G., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-211400 · Cited by 178
Idiopathic Inflammatory Myopathies: Clinical Approach and Management
Malik, A., Hayat, G., Kalia, J. S., & Guzman, M. A. (2016) · Frontiers in Neurology · doi:10.3389/fneur.2016.00064 · Cited by 174
Pinal‐Fernandez, I., Parks, C., Werner, J. L., Albayda, J., Paik, J. J., Danoff, S. K., Casciola‐Rosen, L., Christopher‐Stine, L., & Mammen, A. L. (2017) · Arthritis Care & Research · doi:10.1002/acr.22920 · Cited by 167
A randomized, pilot trial of etanercept in dermatomyositis
The Muscle Study Group (2011) · Annals of Neurology · doi:10.1002/ana.22477 · Cited by 167
Rothwell, S., Cooper, R. G., Lundberg, I. E., Miller, F. W., Gregersen, P. K., Bowes, J., Vencovsky, J., Danko, K., Limaye, V., Selva-O'Callaghan, A., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-208119 · Cited by 166
Sarcoplasmic MxA expression: A valuable marker of dermatomyositis
Uruha, A., Nishikawa, A., Tsuburaya, R. S., Hamanaka, K., Kuwana, M., Watanabe, Y., Suzuki, S., Suzuki, N., & Nishino, I. (2017) · Neurology · doi:10.1212/wnl.0000000000003568 · Cited by 164
Rider, L. G., Lachenbruch, P. A., Monroe, J. B., Ravelli, A., Cabalar, I., Feldman, B. M., Villalba, M. L., Myones, B. L., Pachman, L. M., Rennebohm, R. M., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24904 · Cited by 158
Love, L. A., Weinberg, C. R., McConnaughey, D. R., Oddis, C. V., Medsger, T. A., Reveille, J. D., Arnett, F. C., Targoff, I. N., & Miller, F. W. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24702 · Cited by 157
Miller, F. W., Chen, W., OʼHanlon, T. P., Cooper, R. G., Vencovský, J., Rider, L. G., Dankó, K., Wedderburn, L. R., Lundberg, I. E., Pachman, L. M., et al. (2015) · Genes and Immunity · doi:10.1038/gene.2015.28 · Cited by 156
Inclusion body myositis functional rating scale: A reliable and valid measure of disease severity
Jackson, C. E., Barohn, R. J., Gronseth, G., Pandya, S., Herbelin, L. L., & The Muscle Study Group (MSG) (2008) · Muscle & Nerve · doi:10.1002/mus.20958 · Cited by 152
Burlina, P., Billings, S., Joshi, N., & Albayda, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184059 · Cited by 152
Advances in serological diagnostics of inflammatory myopathies
Benvéniste, O., Stenzel, W., & Allenbach, Y. (2016) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000376 · Cited by 151
Rider, L. G., Aggarwal, R., Pistorio, A., Bayat, N., Erman, B., Feldman, B. M., Huber, A. M., Cimaz, R., Cuttica, R. J., de Oliveira, S. K., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-211401 · Cited by 149
Prevalence of sporadic inclusion body myositis and factors contributing to delayed diagnosis
Needham, M., Corbett, A. J., Day, T., et al. (2008) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2008.01.011 · Cited by 147
Whole-body MRI in the assessment of disease activity in juvenile dermatomyositis
Malattia, C., Damasio, M. B., Madeo, A., Pistorio, A., Providenti, A., Pederzoli, S., Viola, S., Buoncompagni, A., Mattiuz, C., Beltramo, A., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202915 · Cited by 146
β‐Amyloid is a substrate of autophagy in sporadic inclusion body myositis
Lünemann, J. D., Schmidt, J., Schmid, D., Barthel, K., Wrede, A., Dalakas, M. C., & Münz, C. (2007) · Annals of Neurology · doi:10.1002/ana.21115 · Cited by 145
Self-citationHerbert, M. K., Stammen‐Vogelzangs, J., Verbeek, M. M., Rietveld, A., Lundberg, I. E., Chinoy, H., Lamb, J. A., Cooper, R. G., Roberts, M., Badrising, U. A., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-206691 · Cited by 145
Targeting protein homeostasis in sporadic inclusion body myositis
Ahmed, M., Machado, P., Miller, A., Spicer, C., Herbelin, L. L., He, J., Noel, J., Wang, Y., McVey, A., Pasnoor, M., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad4583 · Cited by 137
Role of cytokines and chemokines in idiopathic inflammatory myopathies
Paepe, B. D., Creus, K. K., & Bleecker, J. D. (2009) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3283317b31 · Cited by 135
Cardiac involvement in adult and juvenile idiopathic inflammatory myopathies
Schwartz, T., Diederichsen, L. P., Lundberg, I. E., Sjaastad, I., & Sanner, H. (2016) · RMD Open · doi:10.1136/rmdopen-2016-000291 · Cited by 129
Integrated classification of inflammatory myopathies
Allenbach, Y., Benvéniste, O., Goebel, H., & Stenzel, W. (2017) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12380 · Cited by 123
Dysphagia in Inclusion Body Myositis: Clinical Features, Management, and Clinical Outcome
Oh, T. H., Brumfield, K. A., Hoskin, T. L., Kasperbauer, J. L., & Basford, J. R. (2008) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0b013e31818a50e2 · Cited by 116
Hofbauer, M., Wiesener, S. C., Babbe, H., Roers, A., Wekerle, H., Dornmair, K., Hohlfeld, R., & Goebels, N. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0236183100 · Cited by 110
Nuclear actin aggregation is a hallmark of anti-synthetase syndrome–induced dysimmune myopathy
Stenzel, W., Preuße, C., Allenbach, Y., Pehl, D., Junckerstorff, R. C., Heppner, F. L., Nolte, K. W., Aronica, E., Kana, V., Rushing, E. J., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001422 · Cited by 107
Stenzel, W., Goebel, H. H., & Aronica, E. (2012) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2012.01302.x · Cited by 106
Schmidt, J., Rakočević, G., Raju, R. P., & Dalakas, M. C. (2004) · Brain · doi:10.1093/brain/awh148 · Cited by 104
Self-citationvan de Vlekkert, J., Hoogendijk, J. E., de Haan, R. J., Algra, A., van der Tweel, I., van der Pol, W. L., Uijtendaal, E. V., & de Visser, M. (2010) · Neuromuscular Disorders · doi:10.1016/j.nmd.2010.03.011 · Cited by 103
Editorial: A New Classification of Adult Autoimmune Myositis
Senécal, J., Raynauld, J., & Troyanov, Y. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40063 · Cited by 103
Tournadre, A., Lenief, V., & Miossec, P. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27465 · Cited by 102
Day, J. A., Patel, S., & Limaye, V. S. (2016) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2016.11.001 · Cited by 100
Aggarwal, R., Rider, L. G., Ruperto, N., Bayat, N., Erman, B., Feldman, B. M., Oddis, C. V., Amato, A. A., Chinoy, H., Cooper, R. G., et al. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40064 · Cited by 100
Cancer Risk in Dermatomyositis: A Meta-Analysis of Cohort Studies
Olazagasti, J. M., BAEZ, P. J., Wetter, D. A., & Ernste, F. C. (2015) · American Journal of Clinical Dermatology · doi:10.1007/s40257-015-0120-1 · Cited by 95
Pinal‐Fernandez, I., Casciola-Rosen, L. A., Christopher‐Stine, L., Corse, A. M., & Mammen, A. L. (2014) · The Journal of Rheumatology · doi:10.3899/jrheum.141443 · Cited by 95
The role of myokines in muscle health and disease
Lightfoot, A. P., & Cooper, R. G. (2016) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000337 · Cited by 92
Type I interferon and Toll-like receptor expression characterizes inflammatory myopathies
Cappelletti, C., Baggi, F., Zolezzi, F., Biancolini, D., Beretta, O., Severa, M., Coccia, E. M., Confalonieri, P. A., Morandi, L. O., Mora, M., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e31821f440a · Cited by 89
Rider, L. G., Aggarwal, R., Pistorio, A., Bayat, N., Erman, B., Feldman, B. M., Huber, A. M., Cimaz, R., Cuttica, R. J., de Oliveira, S. K., et al. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40060 · Cited by 87
Long-term follow-up of 62 patients with myositis
van de Vlekkert, J., Hoogendijk, J. E., & de Visser, M. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7313-z · Cited by 82
Evaluation of dysphagia by novel real-time MRI
Olthoff, A., Carstens, P.-O., Zhang, S., von Fintel, E., Friede, T., Lotz, J., Frahm, J., & Schmidt, J. (2016) · Neurology · doi:10.1212/wnl.0000000000003337 · Cited by 82
Self-citationAlexanderson, H., Broman, L., Tollbäck, A., Josefson, A., Lundberg, I. E., & Opava, C. H. (2006) · Arthritis Care & Research · doi:10.1002/art.21715 · Cited by 81
Proteomics of rimmed vacuoles define new risk allele in inclusion body myositis
Güttsches, A., Brady, S., Krause, K., Maerkens, A., Uszkoreit, J., Eisenacher, M., Schreiner, A., Galozzi, S., Mertens‐Rill, J., Tegenthoff, M., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24847 · Cited by 81
Moran, E. M., & Mastaglia, F. L. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12445 · Cited by 79
Shah, M., Targoff, I. N., Rice, M. M., Miller, F. W., Rider, L. G., & with the Childhood Myositis Heterogeneity Collaborative Study Group (2013) · Arthritis & Rheumatism · doi:10.1002/art.37985 · Cited by 78
Pharyngeal Dysphagia in Inflammatory Muscle Diseases Resulting from Impaired Suprahyoid Musculature
Langdon, P. C., Mulcahy, K., Shepherd, K., Low, V. H. S., & Mastaglia, F. L. (2011) · Dysphagia · doi:10.1007/s00455-011-9384-7 · Cited by 74
Liu, L. W. C., Tarnopolsky, M. A., & Armstrong, D. (2004) · Canadian Journal of Gastroenterology · doi:10.1155/2004/360537 · Cited by 71
The Clinical Features of Myositis-Associated Autoantibodies: a Review
Gunawardena, H. (2015) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8513-8 · Cited by 71
Guimarães, J. B., Zanoteli, E., Link, T. M., de Camargo, L. V., Facchetti, L., Nardo, L., & Fernandes, A. D. R. C. (2017) · American Journal of Roentgenology · doi:10.2214/ajr.17.17849 · Cited by 69
Price, M. A., Barghout, V. E., Benvéniste, O., Christopher‐Stine, L., Corbett, A. J., de Visser, M., Hilton‐Jones, D., Kissel, J. T., Lloyd, T. E., Lundberg, I. E., et al. (2016) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-150138 · Cited by 64
Self-citationImmune and myodegenerative pathomechanisms in inclusion body myositis
Keller, C. W., Schmidt, J., & Lünemann, J. D. (2017) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.419 · Cited by 64
Self-citationPhysical exercise as a treatment for adult and juvenile myositis
Alexanderson, H. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12481 · Cited by 61
The Immune Response and the Pathogenesis of Idiopathic Inflammatory Myositis: a Critical Review
Ceribelli, A., Santis, M. D., Isailovic, N., Gershwin, M. E., & Selmi, C. F. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-016-8527-x · Cited by 61
Rothwell, S., Cooper, R. G., Lundberg, I. E., Gregersen, P. K., Hanna, M. G., Machado, P., Herbert, M. K., Pruijn, G. J. M., Lilleker, J. B., Roberts, M., et al. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40045 · Cited by 60
Schmidt, J., Barthel, K., Zschüntzsch, J., Muth, I. E., Swindle, E. J., Hombach, A., Sehmisch, S., Wrede, A., Lühder, F., Gold, R., et al. (2012) · Brain · doi:10.1093/brain/aws046 · Cited by 58
Self-citationHallowell, R. W., & Danoff, S. K. (2014) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000104 · Cited by 53
Inclusion body myositis: advancements in diagnosis, pathomechanisms, and treatment
Schmidt, K., & Schmidt, J. (2017) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000436 · Cited by 49
Self-citationPinal‐Fernandez, I., Casciola-Rosen, L. A., Christopher-Stine, L., Corse, A. M., & Mammen, A. L. (2015) · PubMed · Cited by 48
Role of non-immune mechanisms of muscle damage in idiopathic inflammatory myopathies
Coley, W., Rayavarapu, S., & Nagaraju, K. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3791 · Cited by 42
Environmental Agents and Autoimmune Diseases
Miller, F. W. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-8216-2_6 · Cited by 41
Lightfoot, A. P., Nagaraju, K., McArdle, A., & Cooper, R. G. (2015) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000212 · Cited by 38
Park, J. K., Mecoli, C. A., Alexanderson, H., Regardt, M., Christopher‐Stine, L., Casal-Domínguez, M., de Groot, I., Sarver, C., Lundberg, I. E., Bingham, C. O., et al. (2017) · The Journal of Rheumatology · doi:10.3899/jrheum.161252 · Cited by 37
Clinicopathologic features of myositis patients with CD8-MHC-1 complex pathology
Ikenaga, C., Kubota, A., Kadoya, M., Taira, K., Uchio, N., Hida, A., Maeda, M. H., Nagashima, Y., Ishiura, H., Kaida, K., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004333 · Cited by 37
Muth, I. E., Zschüntzsch, J., Kleinschnitz, K., Wrede, A., Gerhardt, E., Balcarek, P., Schreiber‐Katz, O., Zierz, S., Dalakas, M. C., Voll, R. E., et al. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.05.023 · Cited by 33
Self-citationBeta-Amyloid is a Substrate of Autophagy in Sporadic Inclusion Body Mysositis
Lünemann, J. D., Schmidt, J., Schmid, D., Barthel, K., Wrede, A., Dalakas, M., & Münz, C. (2007) · Aktuelle Neurologie · doi:10.1055/s-2007-987613 · Cited by 31
Self-citationGastrointestinal and Hepatic Disease in the Inflammatory Myopathies
Gadiparthi, C., Hans, A. K., Potts, K. J., & Ismail, M. K. (2017) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2017.09.006 · Cited by 31
Alfano, L. N., Lowes, L. P., Dvorchik, I., Yin, H., Maus, E., Flanigan, K. M., & Mendell, J. R. (2013) · Neuromuscular Disorders · doi:10.1016/j.nmd.2013.11.012 · Cited by 30
Scanning for Therapeutic Targets within the Cytokine Network of Idiopathic Inflammatory Myopathies
Paepe, B. D., & Zschüntzsch, J. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160818683 · Cited by 28
Molecular treatment effects of alemtuzumab in skeletal muscles of patients with IBM
Schmidt, K., Kleinschnitz, K., Rakočević, G., Dalakas, M. C., & Schmidt, J. (2016) · BMC Neurology · doi:10.1186/s12883-016-0568-5 · Cited by 25
Self-citationDevelopment of the sporadic inclusion body myositis physical functioning assessment
DeMuro, C., Lewis, S., Lowes, L. P., Alfano, L. N., Tseng, B. S., & Gnanasakthy, A. (2016) · Muscle & Nerve · doi:10.1002/mus.25079 · Cited by 21
Dysregulated innate immune function in the aetiopathogenesis of idiopathic inflammatory myopathies
Day, J. A., Otto, S., Proudman, S., Hayball, J. D., & Limaye, V. S. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.09.019 · Cited by 20
A protocol to develop clinical guidelines for inclusion‐body myositis
Jones, K. L., Sejersen, T., Amato, A. A., Hilton‐Jones, D., Schmidt, J., Wallace, A., Badrising, U. A., Rose, M. R., & the Ibm Guideline Development Group (2016) · Muscle & Nerve · doi:10.1002/mus.25036 · Cited by 13
Self-citationRecent clinical trials in idiopathic inflammatory myopathies
Leclair, V., & Lundberg, I. E. (2017) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000430 · Cited by 13
Reliability of the Adult Myopathy Assessment Tool in Individuals With Myositis
Harris‐Love, M. O., Joe, G. O., Davenport, T. E., Koziol, D. E., Abbett, K., Shrader, J. A., Vasconcelos, O. M., McElroy, B., & Dalakas, M. C. (2014) · Arthritis Care & Research · doi:10.1002/acr.22473 · Cited by 10
Novel insights of disability assessment in adult myositis
Espinosa-Ortega, H. F., Moreno-Ramírez, M., & Alexanderson, H. (2017) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000433 · Cited by 7
Treatment strategies for inclusion body myositis
Breithaupt, M., & Schmidt, J. (2014) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2014.966688 · Cited by 5
Self-citation
Cited by
Idiopathic inflammatory myopathies
Lundberg, I. E., Fujimoto, M., Vencovsky, J., Aggarwal, R., Holmqvist, M., Christopher-Stine, L., Mammen, A. L., & Miller, F. W. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00321-x · Cited by 703
Metadata
- Authors
- Schmidt, J.
- Venue
- Journal of Neuromuscular Diseases
- Publisher
- SAGE Publications
- Published
- 2018-05-29
- Volume
- 5
- Issue
- 2
- Pages
- 109-129
- ISSN
- 2214-3599 (ISSN-L)
- 2214-3602
- OpenAlex
- W2805713484
- Cited by
- 324
- References
- 126
- FWCI
- 20.80
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.